Emmis Acquisition Corp (EMIS) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Emmis Acquisition Corp   (NASDAQ: EMIS)


Emmis Acquisition's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Emmis Acquisition's ROI in the second quarter of 2026?
Emmis Acquisition Corp achieved a return on average invested assets (ROI) of 4.35 % in its second quarter of 2026, this is above EMIS's average return on investment of -12230.29%.
Emmis Acquisition Corp invested over the 12 months ending in its second quarter of 2026 $59 million

Despite the deterioration in its net income, company has improved ROI compared to the first quarter of 2026.

Within the Healthcare sector 98 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 1381 to 1886.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
II. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM -51.6 % - - - -
Investment (TTM) in Millions 1 118 117 1 0
Return On Investment (TTM) 4.35 % 3.06 % 23.54 % -1342.23 % -109.04 %
EMIS's Overall Ranking # 1886 # 1381 # 0 # 33 # 38
Seq. Investment Change TTM 0.31 % 102 % - - -
Seq. Net Income Change TTM 42.54 % -73.73 % -34.09 % 96.09 % -
Net Income (TTM) in Millions 3 2 7 10 5

EMIS Company Profile >> Back to EMIS Roi Comparisons >> See Annual EMIS Return On Investment



Return On Investment EMIS's Ranking
Within: No.
Industry # 26
Sector # 99
Overall # 1886

Return On Investment Statistics
High Average Low
5640.22 %
-12230.29 %
-98844.72 %
(Mar 31 2014)   (Jun 30 2015)







Financial Statements
Emmis Acquisition's II. Quarter Investments $ 1 Millions EMIS's Balance sheet
Emmis Acquisition's II. Quarter Income $ 1 Millions Quarterly EMIS's Income Statement
EMIS's Income by Division See EMIS's Income by Division


EMIS Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015		 (Dec 31 2014)
2014		 (Dec 31 2013)
2013
Total Investments in Millions 117 -3 -7 -2 -1
Y / Y Investment Growth - - - - -
Net Income in Millions 1 -10 -40 -25 -21
Y / Y Net Income Growth - - - - -
Annual Return On Investment 0.72 % - - - -


Annual Roi Comment
In the fiscal year 2025 ROI deteriorated to 0.72 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
EMIS's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for EMIS's Competitors
Subscribers only: Roi for Emmis Acquisition's Suppliers
Subscribers only: Return On Investment for EMIS's Customers

Other Ratios
EMIS's Roa EMIS's Inventory Turnover Ratio EMIS's Growth Rates EMIS's Dividend Statistics
EMIS's Profitability Ratios EMIS's Asset Turnover Ratio EMIS's Dividend Growth
EMIS's Roe EMIS's Valuation Ratios EMIS's Financial Strength Ratios EMIS's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Ligand Pharmaceuticals Incorporated  11.93 %
Lifevantage Corp  11.84 %
Regeneron Pharmaceuticals Inc   11.83 %
Protagonist Therapeutics inc   11.66 %
Encompass Health Corporation  11.56 %
Embecta Corp   11.20 %
Lemaitre Vascular Inc   11.20 %
3m Company  11.16 %
Globus Medical Inc   11.01 %
National Healthcare Corp  10.91 %
Bioventus Inc   10.85 %
Infusystem Holdings Inc  10.53 %
Livanova Plc  10.40 %
Beone Medicines Ltd   10.32 %
Entrada Therapeutics Inc   10.15 %
Jazz Pharmaceuticals Plc  10.06 %
Prestige Consumer Healthcare Inc   10.06 %
Tactile Systems Technology Inc   10.02 %
Tenet Healthcare Corp  9.98 %
Nature s Sunshine Products inc   9.91 %
Boston Scientific Corporation  9.91 %
Align Technology inc   9.50 %
Pediatrix Medical Group Inc   9.18 %
Abbvie Inc   9.11 %
Ani Pharmaceuticals Inc  9.09 %
Viemed Healthcare Inc   8.97 %
Stryker Corp  8.80 %
Penumbra Inc  8.71 %
Utah Medical Products Inc  8.70 %
Edwards Lifesciences Corporation  8.39 %

Date modified: 2026-09-26T07:43:24+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.